The Chicago Entrepreneur

A norovirus vaccine could be on the horizon as cases rise

Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

Editorial Team

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Data Update 2 for 2025: The Party Continued (for US Equities)
Next post Data Update 2 for 2025: The Party Continued (for US Equities)